Speaker Profile
PMWC PIONEER AWARD
Outstanding contributions to precision medicine include analyzing large-scale biomedical data, uncovering novel insights to improve patient care, and impacting the field through research on big data analysis, drug repurposing, biomarker discovery, patient stratification, and data-driven clinical decision support
M.D., Ph.D., Institute Director and Distinguished Professor, UCSF
Biography
Atul Butte is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and Director of the Bakar Computational Health Sciences Institute at UCSF. Dr. Butte is also the Chief Data Scientist over all 6 academic health centers and 10 hospitals of the University of California Health System, the eighth largest by revenue in the United States. Dr. Butte has been continually funded by NIH for 25 years, is an inventor on 24 patents, and has authored over 300 publications, with research repeatedly featured in the New York Times and Wall Street Journal. Dr. Butte was elected into the National Academy of Medicine in 2015 and was recognized by the Obama Administration as a White House Champion of Change in 2013. Dr. Butte is also a cofounder of three investorbacked datadriven companies: Personalis (IPO, 2019), medical genome sequencing, Carmenta (acquired by Progenity, 2015), pregnancy complication diagnostics, and NuMedii, finding new drugs using AI.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair:
- William Oh, Mount Sinai
Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - is becoming instrumental in the drug development process and for health care decisions in general. This data is not only informative for the process from discovery to new indications, clinical trial design, and drug development, it also can be of value to monitor post-marketing drug safety and for decision support in clinical practice. As the data becomes a decision driver, science companies and medical organizations are increasingly focused on leveraging RWD and RWE to not only better understand the patient populations using their drugs and the respective outcomes, but also to accelerate clinical decision support. This session will focus on the various aspects of integrating RWE and RWD to support drug development and clinical decision support.
Sessions:
- PMWC 2024 Award Ceremony
Pioneer Honoree: Atul Butte, UCSF
- Fostering Collaboration: Strategies to Enhance Data Sharing in Medical Research (PANEL)
Chair: Craig Eagle, Guardant Health
- Paul Boutros, UCLA
- Atul Butte, UCSF
- George Sledge, Caris Life Sciences
- Erica Galvez, Manifest MedEx - Regulatory Challenges in Collecting and Using Race and Ethnicity Data in Real-World Evidence
Chair: Susan Winkler, Reagan-Udall Center
- Multi-Modal Datasets & RWE/D: Pioneering Tools for Accelerated Biomedical Research
Chair: TBA
- Data Privacy and Security in RWE/D
Chair: Deven McGraw, Invitae
- Christopher Boone, AbbVie
- Susan Stayn, Stanford
- Alexa Berk King, CVS
- Accelerating Drug Development Approvals Using RWE/D (PANEL)
Chair: Maria Karasarides, BMS
- Leo Russo, Pfizer
- Eric Schadt, Ethos AI
- Ashley Brenton, Optum
